These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 38375169)

  • 21. Informing iQOS Regulations in the United States: A Synthesis of What We Know.
    Berg CJ; Bar-Zeev Y; Levine H
    Sage Open; 2020; 10(1):. PubMed ID: 32719733
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Exploring the association between the proximity to and density around schools of retailers selling IQOS products and youth use of heated tobacco products: evidence from the 2020-2021 COMPASS study.
    Mott H; Leatherdale ST; Cole AG
    Health Promot Chronic Dis Prev Can; 2024 Jan; 44(1):1-8. PubMed ID: 38231088
    [TBL] [Abstract][Full Text] [Related]  

  • 23. IQOS point-of-sale marketing strategies in Israel: a pilot study.
    Bar-Zeev Y; Levine H; Rubinstein G; Khateb I; Berg CJ
    Isr J Health Policy Res; 2019 Jan; 8(1):11. PubMed ID: 30642383
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Perceived relative harm of heated tobacco products (IQOS), e-cigarettes, and cigarettes among adults in Canada: Findings from the ITC Project.
    Sutanto E; Miller CR; Smith DM; O'Connor RJ; Gravely S; Hammond D; Hyland A; Cummings KM; Quah ACK; Fong GT; Agar TK; Goniewicz ML
    Tob Induc Dis; 2020; 18():81. PubMed ID: 33013277
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence of heated tobacco product use among adolescents in Taiwan.
    Chang LC; Lee YC; Hsu C; Chen PC
    PLoS One; 2020; 15(12):e0244218. PubMed ID: 33347476
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Social Media Discussions on the FDA's Modified Risk Tobacco Product Authorization of IQOS.
    Jun J; Zhang N; Zain A; Mohammadi E
    Subst Use Misuse; 2022; 57(3):472-480. PubMed ID: 34986075
    [No Abstract]   [Full Text] [Related]  

  • 27. IQOS point-of-sale marketing: a comparison between Arab and Jewish neighborhoods in Israel.
    Khayat A; Levine H; Berg CJ; Abroms LC; Duan Z; Wang Y; LoParco CR; Elbaz D; Cui Y; Bar-Zeev Y
    Res Sq; 2024 Mar; ():. PubMed ID: 38464035
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of Visual Exposure to IQOS Use on Smoking Urge and Behavior.
    Brett EI; Miloslavich K; Vena A; Didier N; King AC
    Tob Regul Sci; 2021 Jan; 7(1):31-45. PubMed ID: 34327281
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 'It's not what you'd term normal smoking': a qualitative exploration of language used to describe heated tobacco product use and associated user identity.
    East KA; Miller CR; Hitchman SC; McNeill A; Tompkins CNE
    Addiction; 2023 Mar; 118(3):533-538. PubMed ID: 36148622
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Proximity of IQOS and JUUL points of sale to schools in Israel: a geospatial analysis.
    Elbaz D; Bar Zeev Y; Berg CJ; Abroms LC; Levine H
    Tob Control; 2022 Dec; 31(e2):e156-e161. PubMed ID: 34753792
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Awareness, experience and prevalence of heated tobacco product, IQOS, among young Korean adults.
    Kim J; Yu H; Lee S; Paek YJ
    Tob Control; 2018 Nov; 27(Suppl 1):s74-s77. PubMed ID: 30158210
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analysis of FDA's IQOS marketing authorisation and its policy impacts.
    Lempert LK; Glantz S
    Tob Control; 2020 Jun; ():. PubMed ID: 32601147
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reaching consumers: How the tobacco industry uses email marketing.
    Brock B; Carlson SC; Moilanen M; Schillo BA
    Prev Med Rep; 2016 Dec; 4():103-6. PubMed ID: 27413669
    [TBL] [Abstract][Full Text] [Related]  

  • 34. "It's Like Jogging Next to the Highway": A Qualitative Analysis of the Motivations and Experiences of Single-, Dual-, and Ex-Users of IQOS in The Netherlands.
    Havermans A; van Nierop LE; Pauwels CGGM; Talhout R
    Toxics; 2022 May; 10(6):. PubMed ID: 35736892
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Examining perceptions about IQOS heated tobacco product: consumer studies in Japan and Switzerland.
    Hair EC; Bennett M; Sheen E; Cantrell J; Briggs J; Fenn Z; Willett JG; Vallone D
    Tob Control; 2018 Nov; 27(Suppl 1):s70-s73. PubMed ID: 29764957
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Heated tobacco product (IQOS) induced pulmonary infiltrates.
    Thomas M; Hameed M; Alhadad S; Haq IU
    Respir Med Case Rep; 2024; 49():102026. PubMed ID: 38712315
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Correlates of Awareness and Use of Heated Tobacco Products in a Sample of US Young Adults in 2018-2019.
    Dunbar MS; Seelam R; Tucker JS; Rodriguez A; Shih RA; D'Amico EJ
    Nicotine Tob Res; 2020 Dec; 22(12):2178-2187. PubMed ID: 32047910
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Heated tobacco product use and associated factors among U.S. youth, 2019.
    Dai H
    Drug Alcohol Depend; 2020 Sep; 214():108150. PubMed ID: 32645682
    [TBL] [Abstract][Full Text] [Related]  

  • 39. IQOS labelling will mislead consumers.
    McKelvey K; Popova L; Kim M; Lempert LK; Chaffee BW; Vijayaraghavan M; Ling P; Halpern-Felsher B
    Tob Control; 2018 Nov; 27(Suppl 1):s48-s54. PubMed ID: 30158208
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Categorizing IQOS-Related Twitter Discussions.
    Barker JO; Vassey J; Chen-Sankey JC; Allem JP; Cruz TB; Unger JB
    Int J Environ Res Public Health; 2021 Apr; 18(9):. PubMed ID: 33946546
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.